Panacea Biotec posts Q3 FY2023 net profit at Rs.19.37 crores
The company has reported total income of Rs.129.14 crores during the period ended December 31, 2022 as compared to Rs.157.54 crores during the period ended December 31, 2021.
The company has reported total income of Rs.129.14 crores during the period ended December 31, 2022 as compared to Rs.157.54 crores during the period ended December 31, 2021.
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Revenue from operations during the quarter was up by 6.7 per cent to Rs 6,407.10 crore against Rs 6,002.2 in the same period last fiscal.
The forecast across the seven years between 2022 and 2028 saw an average decline of 7%, resulting in a $10 billion drop in the total forecast sales between 2021 and 2028
With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India
At the end of the inspection, the facility received two observations, one on written production process control procedure and the other on investigation procedure
Company has provided Image Transmission and Reporting of Radiology Images and Selective Radiology Services (X-ray Tele Radiology Services) across all districts in the state of Tripura during the month of June, 2022 and operationalized its services at all the allocated places as on date.
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
The Tc 99m Mertiatide Injection is used in the diagnosis of congenital and acquired renal abnormalities
Subscribe To Our Newsletter & Stay Updated